Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation. (5th September 2017) - Cavalli, Giulio; Koenders, Marije; Kalabokis, Vassili; Kim, Jihye; Choon Tan, Aik; Garlanda, Cecilia; Mantovani, Alberto; Dagna, Lorenzo; Joosten, Leo A. B.; Dinarello, Charles A.